Oct 10 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2017 Aug 31, 2016 Aug 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 15.14 14.63 15.50 7.70
(+3.5 pct) (+1.5 pct) (+2.4 pct) (+5.0 pct)
Operating 1.07 890 mln 1.17 620 mln
(+20.0 pct) (-6.3 pct) (+9.4 pct) (+36.0 pct)
Recurring 1.04 812 mln 1.12 600 mln
(+28.1 pct) (-8.9 pct) (+7.7 pct) (+35.9 pct)
Net
Net 465 mln 489 mln 660 mln 350 mln
(-4.8 pct) (-19.1 pct) (+41.7 pct) (+53.1 pct)
EPS 38.48 yen 40.47 yen 54.50 yen 28.90 yen
EPS Diluted 40.34 yen
Ann Div 10.00 yen 15.00 yen 10.00 yen
-Q2 Div 5.00 yen 5.00 yen 5.00 yen
-Q4 Div 5.00 yen 10.00 yen 5.00 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T
((Tokyo Headline News Desk +813 6441 1812))